Results of a Phase II Open-Label Trial of Bortezomib in Patients with Multiple Myeloma Who Have Undergone High-Dose Melphalan Therapy Followed by Autologous Peripheral Blood Stem Cell Transplantation and Failed to Achieve a Complete Response.

被引：0
|
作者：
Rifkin, Robert M. [1 ,2 ]
Spitzer, Gary [1 ,3 ]
Greenspan, Andrew [1 ,4 ]
Schwerkoske, John F. [1 ,5 ]
Mandanas, Romeo A. [6 ]
Stephenson, Joe [1 ,3 ]
Kannarkat, George T. [1 ,7 ]
Zhan, Feng [1 ]
Asmar, Lina [1 ]
Beveridge, Roy [1 ,7 ]
机构：
[1] US Oncol Res Inc, Houston, TX USA
[2] Rocky Mt Canc Ctr, Denver, CO USA
[3] Canc Ctr Carolinas, Greenville, SC USA
[4] Cent Indiana Canc Ctr, Indianapolis, IN USA
[5] Minnesota Oncol Hematol, St Paul, MN USA
[6] Canc Care Associates W, Oklahoma City, OK USA
[7] Fairfax No Virginia Hematol Oncol, Fairfax, VA USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：960 / 960
页数：1
相关论文
共 50 条
  • [21] Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients
    Martino, Massimo
    Pratio, Giulia
    Messina, Giuseppe
    Irrera, Giuseppe
    Massara, Elisabetta
    Messina, Giuseppe
    Console, Giuseppe
    Iacopino, Pasquale
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (05) : 410 - 415
  • [22] High Dose Intravenous Busulfan (BU) and Melphalan (MEL) Followed by Bortezomib (BTZ) as Conditioning with Autologous Peripheral Blood Stem Cell Transplantation (ASCT) for Patients with Multiple Myeloma (MM)
    Rodriguez, Tulio E.
    Stiff, Patrick J.
    Smith, Scott E.
    Kaufman, Jonathan L.
    Lee, Mary
    Parthasarathy, Mala
    Earley, Zachary M.
    Lonial, Sagar
    Vesole, David H.
    BLOOD, 2010, 116 (21) : 582 - 582
  • [23] The reason why high-dose melphalan followed by autologous stem-cell transplantation produces good response in multiple myeloma
    Kuroda, Y
    Sakai, A
    Okikawa, Y
    Munemasa, S
    Katayama, Y
    Takimoto, Y
    Okita, H
    Kimura, A
    BLOOD, 2004, 104 (11) : 385B - 385B
  • [24] Use of pegfilgrastim after high-dose melphalan and autologous peripheral blood stem cell transplant in multiple myeloma patients
    Messina, G
    Martino, M
    Console, G
    Praticò, G
    Massara, E
    Moscato, T
    Pucci, G
    Irrera, G
    Callea, V
    Quartarone, E
    Stelitano, C
    Iacopino, P
    BONE MARROW TRANSPLANTATION, 2006, 37 : S306 - S306
  • [25] AN APREPITANT CONTAINING REGIMEN CONTROLS THE DELAYED NAUSEA AND VOMITING ASSOCIATED WITH HIGH-DOSE MELPHALAN FOLLOWED BY AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
    Bechtel, T. P.
    Crawford, B. S.
    Gordon, S. M.
    Penza, S.
    Hofmeister, C.
    Benson, D.
    Devine, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 166 - 166
  • [26] A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Noa Biran
    Scott D. Rowley
    David H. Vesole
    Shijia Zhang
    Michele L. Donato
    Alan P. Skarbnik
    Joshua Richter
    Andrew Pecora
    David S. Siegel
    Bone Marrow Transplantation, 2019, 54 : 1881 - 1891
  • [27] A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Biran, Noa
    Rowley, Scott D.
    Vesole, David H.
    Zhang, Shijia
    Donato, Michele L.
    Skarbnik, Alan P.
    Richter, Joshua
    Pecora, Andrew
    Siegel, David S.
    BONE MARROW TRANSPLANTATION, 2019, 54 (11) : 1881 - 1891
  • [28] A Phase I Dose-Escalation Trial of High-Dose Melphalan with Palifermin for Cytoprotection Followed by Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Normal Renal Function
    Abidi, Muneer H.
    Agarwal, Rishi
    Tageja, Nishant
    Ayash, Lois
    Deol, Abhinav
    Al-Kadhimi, Zaid
    Abrams, Judith
    Cronin, Simon
    Ventimiglia, Marie
    Lum, Lawrence
    Ratanatharathorn, Voravit
    Zonder, Jeffrey
    Uberti, Joseph
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (01) : 56 - 61
  • [29] Long-term results in multiple myeloma treated with high-dose melphalan and autologous peripheral stem cell transplantation and achieving complete remission.
    Martino, Massimo Vincenzo
    Postorino, Maurizio
    Gallo, Giuseppe Alberto
    Irrera, Giuseppe
    Piro, Eugenio
    Messina, Giuseppe
    Neri, Santo
    Al Sayyad, Said
    Fedele, Roberta
    Musolino, Caterina
    Molica, Stefano
    Brugiatelli, Maura
    Nobile, Francesco
    Morabito, Fortunato
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] HIGH-DOSE CHEMORADIOTHERAPY AND AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - RESULTS OF A PHASE-II TRIAL INVOLVING 63 PATIENTS
    FERMAND, JP
    CHEVRET, S
    RAVAUD, P
    DIVINE, M
    LEBLOND, V
    DREYFUS, F
    MARIETTE, X
    BROUET, JC
    BLOOD, 1993, 82 (07) : 2005 - 2009
12345